A recent study published in the Journal of the American College of Cardiology found that high plasma lipoproteins can cause ...

Scientists uncover hidden warning signs that predict heart attacks 30 years in advance, giving doctors a chance to stop them ...

Atherosclerotic cardiovascular disease is a major health concern worldwide and requires effective preventive measures. Lp(a) (lipoprotein [a]) has recently garnered attention as an independent risk ...

New research reveals compelling evidence that hormone replacement therapy may offer significant cardiovascular benefits for ...

Older adults had a higher risk of dementia if they had varied levels of lipoprotein cholesterol. Fluctuating levels of low-density lipoprotein (LDL) cholesterol and total cholesterol in older ...

Olpasiran reduces oxidized phospholipids but not inflammation in cardiovascular disease—what does this mean for clinical care ...

Higher LDL cholesterol levels (≥130 mg/dL) were linked to longer survival in Sardinian nonagenarians, challenging the ...

The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...

Lp(a) is a lipoprotein that travels through the blood. Elevated levels of Lp(a) collect in the arteries, gradually narrowing them and limiting blood supply to the heart, brain, kidneys and legs.

Familial hypercholesterolaemia (FH) is a common autosomal-dominant disorder in most European countries. Patients with FH are characterised by a raised level of low-density lipoprotein cholesterol and ...